KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Inovio Pharmaceuticals (INO) Return on Assets (2016 - 2025)

Inovio Pharmaceuticals (INO) has disclosed Return on Assets for 15 consecutive years, with 1.17% as the latest value for Q4 2025.

  • Quarterly Return on Assets fell 20.0% to 1.17% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 1.17% through Dec 2025, down 20.0% year-over-year, with the annual reading at 0.9% for FY2025, 14.0% down from the prior year.
  • Return on Assets hit 1.17% in Q4 2025 for Inovio Pharmaceuticals, up from 1.26% in the prior quarter.
  • In the past five years, Return on Assets ranged from a high of 0.22% in Q2 2021 to a low of 1.26% in Q3 2025.
  • Historically, Return on Assets has averaged 0.79% across 5 years, with a median of 0.78% in 2022.
  • Biggest five-year swings in Return on Assets: soared 35bps in 2021 and later crashed -56bps in 2022.
  • Year by year, Return on Assets stood at 0.59% in 2021, then fell by -28bps to 0.75% in 2022, then rose by 1bps to 0.74% in 2023, then tumbled by -32bps to 0.98% in 2024, then dropped by -20bps to 1.17% in 2025.
  • Business Quant data shows Return on Assets for INO at 1.17% in Q4 2025, 1.26% in Q3 2025, and 1.19% in Q2 2025.